Mangumpit, Mary Fer G.
HRN: 25-41-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2024
CEFUROXIME 750MG (VIAL)
07/04/2024
07/10/2024
IV
750mg
Q8hours
Urinary Tract Infection
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes